Showing results (641-650 of 667) with videos related to
Sort By:
Pageof 67
Physical Review Letters|October 15, 2013
Measurement of the neutron electric to magnetic form factor ratio at Q2=1.58 GeV2 using the reaction 3He[over →](e[over →],e'n)ppB S Schlimme, P Achenbach, C A Ayerbe Gayoso, et al.Cancer Discovery|April 8, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and ImmunityIsabella C Glitza, Yongwoo David Seo, Christine N Spencer, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021Susan M Swetter, John A Thompson, Mark R Albertini, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019P Kumar Rao, Christopher Barker, Daniel G Coit, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 17, 2024
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024Susan M Swetter, Douglas Johnson, Mark R Albertini, et al.Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2026
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In OncologySusan M Swetter, Douglas Johnson, Mark R Albertini, et al.Nature Medicine|January 22, 2021
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanomaZhuting Hu, Donna E Leet, Rosa L Allesøe, et al.Nature|March 16, 2018
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.European Journal of Cancer (Oxford, England : 1990)|December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysisSimone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.Pageof 67